San Francisco Sentry Investment Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,500
Closed -$48K 464
2014
Q3
$48K Hold
2,500
0.02% 302
2014
Q2
$85K Buy
+2,500
New +$85K 0.04% 254